So a question from Rob, from falling from the floor.
So you talked about the frozen subsystem boundaries in aerospace decades without disruption has persistent government subsidy of their home country.
Aerospace companies contributed to the big freeze. So I think I mean, the difficulty in aerospace is the distance from the original ideas.
To bring it into products is so large, so you can't do that without subsidy.
It's not. It's not the same as doing a tech start-up in your back bedroom, you know, so you've got to do some form of subsidies.
I think what is attractive governments is gearing up and funding gearing.
And so if I might, my knowledge is the British government.
They they require 50 percent gearing.
Now, as soon as you do that, the companies who can provide the gearing get the funding from government and that does bias it towards the status quo.
It does. It does. But I do think it's important to fund these the aerospace sector.
If you don't, then you won't have an aerospace sector nicer much now.
So the other thing is that we've heard, I mean,
the last few days and we know from the press there's a lot of significant policy developments, both here in the UK and in the US and the US.
They passed this this U.S. Innovation Competition Act decisions being made about how to spend huge amounts of money
on science technology in the UK about to publish the innovation strategy and confront some major spending review.
So I guess just to end the Q&A because we don't have much time.
What's the one thing you would advise governments to kind of in times what one thing could they do in
the near term to help unlock our ability to to do more in this to better mobilise the partnership?
So I'll start first with Dalton and with Rob. That's that's a great question.
Thomas,
I happened to be on tickers at the President Council of Science of Advisors on Science and Technology when we essentially advised the government,
select your priorities and invest money in those priorities. Make sure that it's good and fast.
It's executed in agile manner and not the usual government type of undertaking.
When it takes a year to select, it takes in about a year to even allocate the money in three years to get some results.
We did emphasise agility, and I think Rob was talking about it very nicely,
breaking the silence and focussing on agility and less regulatory matters related to research.
I think what we see in the U.S. government spent spending spending agencies of Fed
research supporting agencies is a little bit to regulation and too much regulation,
very, very long process from the submission of proposals to the allocation of money.
So this has the collapse, and I will not again emphasise that everybody which I discuss at the very beginning,
very briefly, this was in the making for a number of years.
So this is really, really a high time for us to have this organisation and fully launch and deploy because if our goal is successful,
we all will be successful because we all know and it has been emphasised by a number of speakers how important it is to
bring the multidisciplinary communities together and actually work on those giant huge problems facing the society.
And Rob, last word on this. OK, so focus is key.
Resources are limited, and the real problem is, is government prepared to have good taste?
You know, you've you you if you go through it, if you try and spread it thinly,
if you try and go through peer review, you're going to go for relatively low risk projects.
You cannot have much impact. So you've got to you've got you've got to who are you going to trust to tonight, that good taste.
And I think that is the key challenge. Once the money's given, you need to be clear about objectives.
You've got to be prepared to cut projects that they're not working, but you've got to take your hands off deliverable and miles.
As I go on about, we'll just fix you on one path and that that will doom a project to failure.
Great. Well, thank you very much by both of you for the really interesting keynotes.
I think that really helped set up the discussions in the breakouts.